Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolism: Comparative effectiveness, safety, and costs
Alex C. Spyropoulos, Veronica Ashton, Yen Wen Chen, Bingcao Wu, Eric D. Peterson
Research output: Contribution to journal › Article › peer-review
50Scopus
citations
Fingerprint
Dive into the research topics of 'Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolism: Comparative effectiveness, safety, and costs'. Together they form a unique fingerprint.